相关实验视频

Updated: Jan 13, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

突变的亨廷丁外子1的蛋白质体退化调节自

Austin Folger¹, Chuan Chen², Phasin Gonzalez³

¹Department of Biomedical Sciences, College of Medicine, Florida State University, 1115 West Call Street, Tallahassee, FL 32306-4300, USA.

|January 9, 2026

概括

亨廷顿病涉及有毒的蛋白质聚合物. 这项研究表明,无处不在,展开和蛋白质体降解是通过酵母体的自 (IBophagy) 清除这些聚合物的关键步骤.

科学领域:

神经退行性疾病的神经退行性疾病
分子生物学分子生物学
细胞机制细胞机制

背景情况:

错误折叠的蛋白质积累,特别是从huntingtin基因 (HTT) 中扩大CAG重复的突变huntingtin exon1 (mHttEx1),驱动神经退行性疾病,如亨廷顿病.
mHttEx1形成细胞毒性聚合物,需要细胞清除途径,如蛋白质体降解和自.
自,特别是包括体的吞 (IBophagy),是这些聚合物的关键降解机制.

研究的目的:

研究将蛋白质体降解与mHttEx1IBophagy联系起来的特定分子步骤.
阐明在自介导的mHttEx1聚合物的清除中,泛化和Cdc48复合物的作用.
揭示控制mHttEx1细胞毒性和清除的新型调节机制.

主要方法:

利用芽生长酵母作为模型生物来研究mHttEx1聚合物清除.
研究了E3酶San1,Cdc48复合体和mHttEx1IBophagy中的蛋白质体降解的作用.
分析了ubiquitination,蛋白质展开和自性降解途径之间的相互作用.

主要成果:

证明了San1对mHttEx1的无处不在对于其随后的提取和Cdc48复合体的展开至关重要.
表明mHttEx1的蛋白质体降解是IBophagy的先决条件.
确定了一种新的调节途径,其中蛋白质体机器促进了mHttEx1.1的自相清除.

结论:

乌比基化,Cdc48介导的展开和蛋白质体降解是mHttEx1IBophagy的关键上游事件.
这项研究揭示了一种新的自调节层,涉及蛋白酶体在毒性蛋白质聚合物的清除中.
了解这些机制,可以了解亨廷顿病和相关疾病的潜在治疗策略.

关键词:

Cdc48 复合物复合物复合物在IBophagy中进行IBophagy.自自是自的过程.错误折叠的蛋白质可能是错误的蛋白质.突变的狩猎丁外子1 (mHttEx1)蛋白质酶体蛋白质组是什么

更多相关视频

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

相关概念视频

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Proteasome

The Proteasome

Autophagy

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

Regulated Protein Degradation

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

Export of Misfolded Proteins out of the ER

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...